Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer

[Image: see text] RIP1 regulates cell death and inflammation and is believed to play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases and cancer. While small-molecule inhibitors of RIP1 kinase have been advanced to the clinic for in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: Harris, Philip A., Marinis, Jill M., Lich, John D., Berger, Scott B., Chirala, Anirudh, Cox, Julie A., Eidam, Patrick M., Finger, Joshua N., Gough, Peter J., Jeong, Jae U., Kang, James, Kasparcova, Viera, Leister, Lara K., Mahajan, Mukesh K., Miller, George, Nagilla, Rakesh, Ouellette, Michael T., Reilly, Michael A., Rendina, Alan R., Rivera, Elizabeth J., Sun, Helen H., Thorpe, James H., Totoritis, Rachel D., Wang, Wei, Wu, Dongling, Zhang, Daohua, Bertin, John, Marquis, Robert W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580371/
https://ncbi.nlm.nih.gov/pubmed/31223438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.9b00108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados